Grufity logoGrufity logo

INSP

239.49USD-0.19(-0.08%)Market Closed

Inspire Medical Systems Inc

Market Summary

USD239.49-0.19Market Closed
-0.08%

INSP Alerts

INSP Stock Price

RSI Chart

Valuation

Market Cap

5.1B

Price/Earnings

-116.67

Price/Sales

17.03

Price/Cashflow

-279.93

MarketCap/EBT

-117.38

Price/Sales

Profitability

EBT Margin

-14.51%

Return on Equity

-19.35%

Return on Assets

-15.04%

Fundamentals

Revenue

Revenue (TTM)

348.4M

Revenue Y/Y

77.01%

Revenue Q/Q

19.48%

Earnings

Earnings (TTM)

-50.4M

Earnings Y/Y

-62.82%

Earnings Q/Q

-16.27%

Price Action

52 Week Range

272.04
(Low)(High)

Last 7 days

4%

Last 30 days

15.9%

Last 90 days

29.3%

Trailing 12 Months

7.4%

Financial Health

Current Ratio

5.62

Investor Care

Shares Dilution (1Y)

5.61%

Diluted EPS (TTM)

-1.82

Peers (Alternatives to Inspire Medical Systems)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
86.7B
17.9B
14.69% -0.88%
41.71
4.92
7.67% 29.32%
86.3B
6.1B
15.30% -16.82%
62.6
14.1
11.47% -18.42%
67.1B
18.9B
10.69% 8.01%
38.21
3.25
-6.81% -14.96%
61.8B
12.3B
11.14% 17.68%
69.9
5.01
10.11% 51.89%
43.9B
5.4B
8.87% -30.30%
30.09
8.18
5.29% -1.25%
MID-CAP
6.7B
998.4M
15.24% 17.79%
44.21
6.87
6.04% -19.01%
6.4B
806.4M
33.98% -14.84%
-331.15
7.96
20.10% -221.96%
5.1B
348.4M
15.87% 7.40%
-116.67
17.03
73.31% -6.97%
3.9B
380.1M
-8.48% 5.83%
-29.57
10.69
18.85% -63.58%
3.5B
1.3B
1.68% -71.29%
56.99
2.75
22.34% -40.14%
2.8B
234.2M
0.32% 74.54%
-326.57
11.85
18.02% 12.02%
SMALL-CAP
1.5B
163.2M
-29.18% -54.62%
-10.23
9.27
35.13% -252.35%
1.0B
795.9M
17.05% -10.97%
-131.34
1.33
8.11% 182.50%
48.1M
29.3M
-6.67% -75.83%
-3.71
1.49
-19.35% -69.01%
6.0M
6.8M
-37.29% -90.95%
-0.27
0.74
-21.00% -36.01%

Financials for Inspire Medical Systems

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue15.8%348301262233201
Gross Profit14.1%293257225200172
Operating Expenses14.6%342299265240217
  S&GA Expenses12.5%252224203182
  R&D Expenses24.6%5846413734
Earnings Before Taxes-14.3%-49.91-43.66-42.37-41.97-47.05
Net Income-14.8%-50.42-43.92-42.52-42.04-47.13
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets80.7%528292290295279
  Current Assets88.3%496263262269255
    Cash Equivalents123.9%418187203214210
  Inventory-30.7%1522221716
  Net PPE28.3%1411988
Liabilities-11.8%5765656659
  Current Liabilities5.2%4947434134
Shareholder's Equity107.2%470227225229220
  Retained Earnings-5.4%-327.42-310.57-296.08-279.39-277.00
  Additional Paid-In Capital48.4%798538521508497
Accumulated Depreciation13.4%44333
Shares Outstanding4.3%2928282727
* denotes actual numbers (not divided by Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations61.9%-6.97-18.31-22.47-20.12-24.96
  Share Based Compensation21.5%4436302623
Cashflow From Investing-202.7%-17.1817292941
Cashflow From Financing1901.9%23212141515

Risks

What is the probability of a big loss on INSP?

87.6%


Probability that Inspire Medical Systems stock will be more than 20% underwater in next one year

69.0%


Probability that Inspire Medical Systems stock will be more than 30% underwater in next one year.

31.4%


Probability that Inspire Medical Systems stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does INSP drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Inspire Medical Systems was unfortunately bought at previous high price.

Returns

Cumulative Returns on INSP

49.1%


3-Year Cumulative Returns

Which funds bought or sold INSP recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-22
B. Riley Wealth Advisors, Inc.
ADDED
1.97
-3,000
276,000
0.01%
2022-11-21
FourThought Financial, LLC
-
-
-3,000
106,000
0.02%
2022-11-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
-
-
-226,000
6,188,000
0.01%
2022-11-17
CENTRAL TRUST Co
REDUCED
-2.9
-1,000
12,000
-%
2022-11-16
CAPTRUST FINANCIAL ADVISORS
SOLD OFF
-100
-238,000
-
-%
2022-11-15
Traynor Capital Management, Inc.
SOLD OFF
-100
-200,000
-
-%
2022-11-15
STATE STREET CORP
ADDED
7.84
4,671,000
103,894,000
0.01%
2022-11-15
BNP PARIBAS ARBITRAGE, SNC
ADDED
131
1,422,990
2,567,780
-%
2022-11-15
Northeast Financial Consultants Inc
UNCHANGED
-
-6,000
231,000
0.02%
2022-11-15
Neuberger Berman Group LLC
REDUCED
-0.29
-77,000
2,341,000
-%

1–10 of 46

Latest Funds Activity

Are funds buying INSP calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own INSP

Inspire Medical Systems News

MarketBeat

Inspire Medical Systems, Inc. (NYSE:INSP) Given Consensus Recommendation of "Moderate Buy" by Brokerages.2 days ago

Seattle PI

INSP Fair Value

Recent SEC filings of Inspire Medical Systems

View All Filings
Date Filed Form Type Document
Nov 14, 2022
4
Insider Trading
Nov 10, 2022
SC 13G/A
Major Ownership Report
Nov 01, 2022
10-Q
Quarterly Report
Nov 01, 2022
8-K
Current Report
Oct 19, 2022
4
Insider Trading
Oct 13, 2022
4
Insider Trading
Oct 13, 2022
4
Insider Trading
Oct 13, 2022
4
Insider Trading
Oct 13, 2022
4
Insider Trading
Oct 13, 2022
4
Insider Trading

Latest Insider Trading transactions for INSP

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-11-11
Griffin Jerry C
SOLD
-2,040,850
221.423
-9,217
-
2022-11-11
Griffin Jerry C
ACQUIRED
10,600.4
0.94
11,277
-
2022-10-17
Jandrich Steven
ACQUIRED
705
0.94
750
VP, Human Resources
2022-10-11
Tansey Casey M
ACQUIRED
13,687.4
168.98
81
-
2022-10-11
NELSON MARILYN C
ACQUIRED
21,798.4
168.98
129
-
2022-10-11
Sparks Charisse Y
ACQUIRED
8,617.98
168.98
51
-
2022-10-11
Broader Shelley G.
ACQUIRED
14,363.3
168.98
85
-
2022-10-11
Herbert Timothy P.
ACQUIRED
326,264
4.74311
68,787
CEO and President
2022-10-11
Ellis Gary Lee
ACQUIRED
14,870.2
168.98
88
-
2022-07-11
Melenikiotou Georgia
ACQUIRED
13,570.2
193.86
70
-

1–10 of 50

Timothy P. Herbert
480
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

INSP Income Statement

2022-09-30
Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($)
$ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]    
Revenue$ 109,188$ 61,685$ 269,956$ 154,996
Cost of goods sold19,7868,62443,96322,123
Gross profit89,40253,061225,993132,873
Operating expenses:    
Research and development20,9939,61447,39727,056
Selling, general and administrative85,60353,243225,853143,846
Total operating expenses106,59662,857273,250170,902
Operating loss(17,194)(9,796)(47,257)(38,029)
Other expense (income):    
Interest and dividend income(1,350)(22)(1,681)(110)
Interest expense6565371,6771,590
Other expense, net1013329090
Total other (income) expense(593)5482861,570
Loss before income taxes(16,601)(10,344)(47,543)(39,599)
Income taxes246348852
Net loss(16,847)(10,347)(48,031)(39,651)
Other comprehensive loss:    
Foreign currency translation loss(148)0(106)0
Unrealized (loss) gain on investments(14)3(202)(38)
Total comprehensive loss$ (17,009)$ (10,344)$ (48,339)$ (39,689)
Net loss per share, basic (in dollars per share)$ (0.60)$ (0.38)$ (1.73)$ (1.46)
Net loss per share, diluted (in dollars per share)$ (0.60)$ (0.38)$ (1.73)$ (1.46)
Weighted average common shares used to compute net loss per share, basic (in shares)28,226,34527,300,37727,782,09327,225,499
Weighted average common shares used to compute net loss per share, diluted (in shares)28,226,34527,300,37727,782,09327,225,499

INSP Balance Sheet

2022-09-30
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 417,808$ 214,467
Investments, short-term9,7410
Accounts receivable, net of allowance for credit losses of $34 and $99, respectively48,49834,179
Inventories15,14617,231
Prepaid expenses and other current assets4,3512,660
Total current assets495,544268,537
Investments, long-term09,938
Property and equipment, net14,1348,486
Operating lease right-of-use assets7,1417,919
Other non-current assets10,704204
Total assets527,523295,084
Current liabilities:  
Accounts payable20,30511,665
Accrued expenses28,98620,454
Notes payable, current portion09,188
Total current liabilities49,29141,307
Notes payable, non-current portion015,799
Operating lease liabilities, non-current portion7,8828,796
Other non-current liabilities146134
Total liabilities57,31966,036
Stockholders' equity:  
Preferred Stock, $0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding00
Common Stock, $0.001 par value per share; 200,000,000 shares authorized; 28,820,680 and 27,416,106 issued and outstanding at September 30, 2022 and December 31, 2021, respectively2927
Additional paid-in capital797,958508,465
Accumulated other comprehensive loss(363)(55)
Accumulated deficit(327,420)(279,389)
Total stockholders' equity470,204229,048
Total liabilities and stockholders' equity$ 527,523$ 295,084